Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
AVI Nabs $11.5M Defense Contract
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/01/09 |
Seattle
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/03/09 |
Seattle
|
|
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain
|
Luke Timmerman |
09/01/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
Jeff Bezos Invests in Robots, MySpace Confirms iLike Purchase, Cell Therapeutics Sells Stock, & More Seattle-Area Deals News
|
Gregory T. Huang |
08/25/09 |
Seattle
|
|
AVI Nails Down $30M
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
AVI Ends June With $20M Cash
|
Luke Timmerman |
08/10/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
AVI Gets Duchenne Funding
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2
|
Luke Timmerman |
07/28/09 |
Seattle
|
|
AVI BioPharma Obtains $1,200,000 New Funding Round
|
VentureDeal |
07/28/09 |
Seattle
|
|
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
AVI Developing Swine Flu Drugs
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
AVI Gets $3M For Muscular Dystrophy
|
Luke Timmerman |
06/04/09 |
Seattle
|
|
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
AVI Wins Part of $2.5M Contract
|
Luke Timmerman |
05/06/09 |
Seattle
|
|
Dendreon Drug Prolongs Life, ZymoGenetics Cuts Staff, Microsoft Tackles Biotech & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/30/09 |
Seattle
|
|
Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts
|
Luke Timmerman |
04/29/09 |
Seattle
|
|
AVI Gets Patent For Ebola Drug
|
Luke Timmerman |
04/28/09 |
Seattle
|
|
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn
|
Luke Timmerman |
03/25/09 |
Seattle
|
|
CG Therapeutics, Immune-Booster For Cancer, Recruits Dendreon Vets, New CEO
|
Luke Timmerman |
03/10/09 |
Seattle
|
|
Seattle Genetics Defies Gravity With Biotech’s First Underwritten Stock Sale in Six Months
|
Luke Timmerman |
02/05/09 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
